These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Significance of cognitive disorders for the classification and behavior therapy of obsessive syndromes]. Süllwold L Nervenarzt; 1973 Oct; 44(10):537-46. PubMed ID: 4765909 [No Abstract] [Full Text] [Related]
15. Body dysmorphic disorder and obsessive-compulsive disorder: similarities, differences and the classification debate. Chosak A; Marques L; Greenberg JL; Jenike E; Dougherty DD; Wilhelm S Expert Rev Neurother; 2008 Aug; 8(8):1209-18. PubMed ID: 18671665 [TBL] [Abstract][Full Text] [Related]
16. [Practice guidelines--therapy of anxiety and compulsive disorders. Recommendations for therapy of anxiety and compulsive disorders of the Drug Commission of the German Medical Society]. Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):241-4. PubMed ID: 10802900 [No Abstract] [Full Text] [Related]
17. [Obsessions and mood: apropos of 43 cases of obsessive neurosis treated with antidepressive chemotherapy and electroshock]. Dubois JC Ann Med Psychol (Paris); 1984 Jan; 142(1):141-51. PubMed ID: 6476671 [No Abstract] [Full Text] [Related]
18. [Current status of obsessional compulsive disorders: theories, epidemiology and treatment]. Bourgeois M; Peyre F; Verdoux H Ann Med Psychol (Paris); 1989 Sep; 147(7):768-75. PubMed ID: 2694888 [No Abstract] [Full Text] [Related]
19. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647 [TBL] [Abstract][Full Text] [Related]